NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Effects of X Box Kinect 360 in Alzheimer's Disease
Effects of X Box Kinect 360 in Alzheimer's Disease

NCT07673263

Not Yet RecruitingNA

Sponsor: Ziauddin University

Conditions: Alzheimer s Disease

Interventions: 3D Kinect based game, Conventional therapy group

Countries: Pakistan

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia that accounting for 60% to 80% of all cases (Better, et al., 2023). According to world health organization (WHO), more than 55 million people globally live with dementia, and this number is expected to rise to 78 million by 2023 and 139 million by 2050 (WHO, 2021).

Eligibility overview

Sex: ALL

Age: 50 Years to 85 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria

* Alzheimer's disease of age between 50-85 years.
* Diagnosed AD stage Mild to Moderate.

Exclusion Criteria:

* Undiagnosed AD patients.
* Mental or neurological conditions like schizophrenia, Parkinson's, or stroke.
Locations (1)
  • Karachi, Sindhi, Pakistan